mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.06 |
mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.06 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.07 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.07 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.07 |
mRNA |
PF-562271 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.07 |